|
Shanghai Pharmaceuticals Hold Co., Ltd is a pharmaceutical industry group listed in Shanghai and Hong Kong, operating as a core enterprise under the controlling shareholder Shanghai Shangshi. The company's principal business covers three main segments: pharmaceutical manufacturing, distribution, and retail. It engages in the research, development, and production of drugs, while also managing a comprehensive supply chain for pharmaceutical products. The group serves the Chinese healthcare market, leveraging its integrated industry chain to connect manufacturing with distribution and retail channels. Key subsidiaries operate within these sectors, contributing to the group's diversified portfolio of healthcare products and services. The company focuses on expanding its international market presence and accelerating the commercialization of new products to address evolving healthcare needs. Summarised from the company's own disclosures, fiscal year ended Apr 2026 |
Industry Drug Manufacturers - General | Homepage sphchina.com |
| Sector Healthcare | IR page sphchina.com/investor_relations | |
|
Tags
innovative drugs, generic medicines, pharmaceutical distribution, pharmaceutical retail, healthcare supply chain, r&d
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | HK$ 40.714B |
| Market cap (USD) | $ 5.189B |
| P/E | 6.36 |
| PEG | — |
| P/BV | 0.37 |
| P/S | 0.19 |
| P/OCF | 7.92 |
| P/FCF | — |
| Dividend yield | 4.7% |
| Turnover / mcap | 0.03% |
| Returns | |
|---|---|
| ROE | — |
| ROI | — |
| ROIC | — |
| Profit margin | — |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | No |
| Revenue up 3y | Yes |
| Revenue up 5y | Yes |
| Earnings growth 3y (net profit CAGR) | -2.7% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | Yes |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | 23.1% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | 186.566B | 159.084B | 130.847B | 120.765B | 105.517B | 92.399B | 78.223B | 68.078B | 54.9B | 38.692B |
| Net profit | — | — | 5.167B | 6.992B | 6.275B | 5.605B | 4.081B | 3.881B | 3.521B | 3.196B | 2.877B | 2.591B | 2.243B | 2.053B | 2.042B | 1.456B |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpAnnouncements and reports published on HKEXnews, newest first, monthly and next-day returns, proxy forms and board-meeting notices included. The link opens the announcement on HKEXnews. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Shanghai Pharmaceuticals Hold Co., Ltd
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| DFSE | 0.03% | 117,800 | $ 164.432K | Nov 12, 2026 |
| DFEV | 0.02% | 356,800 | $ 498.041K | Nov 12, 2026 |
| DFEM | 0.01% | 767,000 | $ 1.071M | Nov 12, 2026 |
| AVSE | 0.01% | 8,900 | $ 12.501K | Nov 16, 2026 |
| DFAE | 0.01% | 570,800 | $ 796.754K | Nov 12, 2026 |
| DFAX | 0.00% | 361,700 | $ 504.881K | Nov 12, 2026 |
| AVEM | 0.00% | 697,600 | $ 979.88K | Nov 16, 2026 |